Publications

This poster presented at the American Society for Mass Spectrometry from Oregon Health Sciences University describes a Proteograph™ application proof-of-concept pilot study on 32 prostate cancer serum specimens retrospectively collected from patients with high and low tumor grades.

This ASMS 2020 poster shows how the Proteograph platform is the first unbiased platform for large-scale proteome profiling studies quantifying thousands of proteins across large numbers of samples.

Compared to typical fractionation, the Proteograph platform has superior coverage, depth, precision, and accuracy in unbiased proteomic profiling.